Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 3.4B | 3.5B | 3.6B | 3.5B |
| Cost of revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | — | 606M | — | — |
| Other operating expenses | 0 | 0 | 0 | 0 |
| Operating income | — | — | — | — |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | — | — | — | — |
| Other income expense | — | — | — | — |
| Pretax income | 1.7B | 1.7B | 1.9B | 1.8B |
| Tax provision | 442M | 425M | 505M | 471M |
| Net income | 1.3B | 1.3B | 1.4B | 1.3B |
| Basic EPS | 19.4 | — | 21.7 | 19.8 |
| Diluted EPS | 19.4 | — | 21.7 | 19.8 |
| Basic average shares | 61.5M | — | 62.4M | 63.8M |
| Diluted average shares | 61.5M | — | 62.4M | 63.8M |
| EBITDA | — | — | — | — |
| Net income from continuing op. | 1.3B | 1.3B | 1.4B | 1.3B |
| Minority interests | — | — | — | — |
| Preferred stock dividends | 65M | 67M | 66M | 67M |